This inventor holds 1 USPTO granted patent. Top assignee: The Kitasato Institute. Active years: 1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983
Title: The Innovations of Yoshimoto Sano
Introduction
Yoshimoto Sano is a notable inventor based in Tokyo, Japan. He is recognized for his significant contributions to the field of pharmaceuticals, particularly in the development of interferon inducers. His work has implications for antiviral treatments and showcases the intersection of natural substances and modern medicine.
Latest Patents
Yoshimoto Sano holds a patent for an interferon inducer, which is a process for producing the same and pharmaceutical compositions. This interferon inducer is isolated from plant tissue and has a unique elemental analysis, including H: 8.5-8.7 %, C: 48.8-49 %, N: 6.3-6.5 %, and P: 1.0-1.1 %. The molecular weight of this substance ranges from about 100,000 to about 3,000,000, primarily around 200,000 to about 1,000,000. It contains amino acids, sugars, and phosphoric acid, believed to be a homogeneous polymer of protein and sugars. This substance exhibits excellent interferon-inducing activity with low toxicity and is significantly effective against various viruses. The production process involves extracting the active substance from the tissue of a plant of the genus Perilla, utilizing water for extraction and ultrafiltration for recovery.
Career Highlights
Yoshimoto Sano is affiliated with The Kitasato Institute, where he conducts his research and development work. His innovative approach to utilizing plant-based substances for pharmaceutical applications has garnered attention in the scientific community.
Collaborations
He has collaborated with notable colleagues, including Seishi Konno and Yasuhiko Kojima, contributing to advancements in their shared field of research.
Conclusion
Yoshimoto Sano's work in developing interferon inducers represents a significant advancement in antiviral therapies. His innovative research continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile